Cartesian Therapeutics (RNAC) Times Interest Earned (2016 - 2023)
Cartesian Therapeutics (RNAC) has disclosed Times Interest Earned for 9 consecutive years, with -$10.26 as the latest value for Q3 2023.
- For Q3 2023, Times Interest Earned fell 414.76% year-over-year to -$10.26; the TTM value through Jun 2024 reached -$38.48, down 158.84%, while the annual FY2023 figure was -$30.5, 735.96% down from the prior year.
- Times Interest Earned hit -$10.26 in Q3 2023 for Cartesian Therapeutics, up from -$24.78 in the prior quarter.
- Across five years, Times Interest Earned topped out at $19.38 in Q2 2022 and bottomed at -$79.84 in Q2 2020.
- Average Times Interest Earned over 5 years is -$19.9, with a median of -$11.08 recorded in 2020.
- Year-over-year, Times Interest Earned soared 2949.22% in 2022 and then crashed 414.76% in 2023.
- Cartesian Therapeutics' Times Interest Earned stood at -$37.52 in 2019, then skyrocketed by 70.48% to -$11.08 in 2020, then soared by 151.78% to $5.74 in 2021, then plummeted by 283.55% to -$10.53 in 2022, then increased by 2.51% to -$10.26 in 2023.
- According to Business Quant data, Times Interest Earned over the past three periods came in at -$10.26, -$24.78, and -$22.75 for Q3 2023, Q2 2023, and Q1 2023 respectively.